Substance Use Tools & Resources    

This Quick Take outlines the legal and policy efforts that have led to an increase in availability and stresses the importance of continued advocacy efforts to further expand MOUD availability in jails and prisons and in the community.

The National Strategy includes recommendations developed by the Task Force on Maternal Mental Health, a subcommittee of SAMHSA’s Advisory Committee for Women’s Services, to address the urgent public health crisis of maternal mental health and substance use issues.

This guideline provide evidence-based strategies and standards of care for the treatment of stimulant use disorders, stimulant intoxication, and stimulant withdrawal, as well as secondary and tertiary prevention of harms associated with stimulant use.

Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.

Designed for people who work in health-related fields, this interactive site will help you learn how stigma can impact the healthcare and support women need, seek and receive.

This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.

Moms in Recovery is a program for pregnant and parenting women who struggle with substance use, and form close relationships with counselors, psychiatrists, midwives, pediatricians, case managers and recovery coaches.

This toolkit introduces best practices to support and improve the quality of care for substance exposed mothers and newborns.

This Topic Brief discusses perinatal behavioral health conditions, which include mental health and substance use disorders during pregnancy and the postpartum period (up to 12 months after delivery).

The Project RESPECT team supports patients throughout their recovery journey during the entire first year postpartum and offer monitored, acute substance withdrawal treatment and induction of medications for opioid use disorder in pregnant patients seeking treatment.